文献速递肝病

减重手术与标准肥胖治疗对严重肝病风险的影响:瑞典肥胖受试者研究数据

Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-11-05

本研究基于瑞典肥胖受试者(SOS)队列,分析减重手术与标准肥胖治疗对肝脏相关结局的影响。原文仅提供背景与目的,未报告具体样本量、随访时间、效应值或统计学显著性,故无法给出疗效结论。

要点

  • 肥胖与NAFLD密切相关,少数患者可进展为肝硬化及终末期肝病。
  • 减重可改善NAFLD患者肝脏组织学,但长期维持体重困难。
  • 减重手术可改善糖耐量、减轻体重并降低总体死亡率,对肝脏结局的影响尚不明确。

研究设计与样本

  • 基于瑞典肥胖受试者(SOS)队列分析肝脏相关结局。

局限性

  • 原文仅提供背景与目的,未报告具体样本量、随访时间、效应值或统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is closely associated with nonalcoholic fatty liver disease. A minority of patients with nonalcoholic fatty liver disease progress to liver cirrhosis and end-stage liver disease.1 Weight loss results in improvement of liver histology in persons with nonalcoholic fatty liver disease.2 Because weight loss can be challenging to achieve and sustain in persons with obesity, bariatric surgery is considered a feasible therapeutic option for persons with severe obesity.3 Bariatric surgery leads to improved glucose tolerance, weight loss, and improved overall mortality.4 It is less well known if bariatric surgery also reduces the incidence of liver-related outcomes. Here, we analyzed liver-related outcomes in the Swedish Obese Subjects (SOS) cohort.5.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Hagström H, Ekstedt M, Olbers T, et al. Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study. Clin Gastroenterol Hepatol. 2020. PMID: 33161161. doi:10.1016/j.cgh.2020.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。